Clinical trial
Dose-dependent Effect of Grape Seed Extract (GSE) on Glucose Control in People With Impaired Glucose Tolerance
NCT02254317 is registered in ClinicalTrials.gov with Clinical Nutrition Research Center, Illinois Institute of Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dose-dependent Effect of Grape Seed Extract (GSE) on Glucose Control in People With Impaired Glucose Tolerance
- Lead sponsor
- Clinical Nutrition Research Center, Illinois Institute of Technology
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 15, 2014
- Completion date
- July 1, 2015
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
impaired glucose tolerance